CM
IHI icon

Castleark Management’s iShares US Medical Devices ETF IHI Stock Holding History

Castleark Management’s Portfolio IHI Stock Details IHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-157,940
Closed -$8.92M – 296
2023
Q2 		$8.92M Buy
+157,940
New +$8.7M 0.4% 50

Other funds holding IHI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Castleark Management's IHI Position: Q3 2023 in Review

Castleark Management sold out of iShares US Medical Devices ETF (IHI) in Q3 2023, closing a stake of 157,940 shares — an estimated $8.92M sold.

Castleark Management first reported a position in IHI in Q2 2023 and held it in 1 quarter. The position peaked at $8.92M in Q2 2023. 544 funds tracked by Wall St. Rank hold IHI as of Q3 2023.

  • Castleark Management reported no remaining iShares US Medical Devices ETF position as of Q3 2023 after selling out during the quarter.
  • Castleark Management sold 157,940 iShares US Medical Devices ETF shares in Q3 2023, an estimated $8.92M.
  • Castleark Management first reported a position in iShares US Medical Devices ETF in Q2 2023 and held it in 1 quarter.
  • Castleark Management's iShares US Medical Devices ETF position peaked at $8.92M in Q2 2023.
  • 544 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2023.

Based on Castleark Management's 13F filing for Q3 2023, filed 15 Nov 2023.